PR1 vaccination in myeloid malignancies (Q37259568)

19 August 2017

1 reference

title

PR1 vaccination in myeloid malignancies (English)

1 reference

19 August 2017

Katayoun Rezvani

1 reference

19 August 2017

publication date

1 September 2008

1 reference

Expert Review of Vaccines

19 August 2017

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

867-875

1 reference

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Adoptive immunotherapy in canine chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Human minor histocompatibility antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

The phylogeny of proteinase 3/myeloblastin, the autoantigen in Wegener's granulomatosis, and myeloperoxidase as shown by immunohistochemical studies on human leukemic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Antigen presentation--recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Peptide-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Can leukemia-derived dendritic cells generate antileukemia immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

DNA vaccines against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Evidence for a differential avidity model of T cell selection in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Limit of T cell tolerance to self proteins by peptide presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Regulatory T cells: key controllers of immunologic self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

T-cell therapy of cytomegalovirus and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.7.867

21 January 2018

Identifiers

DOI

10.1586/14760584.7.7.867

1 reference

release_virjsxruwbcrnlpdnmbsbvs3gi

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/virjsxruwbcrnlpdnmbsbvs3gi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference